Physicians iTrack™ Molteno3®

Overview AlphaRET

Investors ASX Announcements Presentations Share Registry Board of Directors Corporate Governance

ASX Announcements

Five-Year Post-LEAD Review Shows Improvement in 2RT^® Treatment Benefits for iAMD

ASX Announcement General AlphaRET

5 Mar, 2021

Nova Eye Medical Establishes AlphaRET to Support Commercial Development of 2RT^®

ASX Announcement AlphaRET

26 Oct, 2020

View Media Releases

For investor enquires please contact:

Dr. Tom Duthy
Nova Eye Medical Limited
W +61 402 493 727
tduthy@nova-eye.com

This website uses cookies to ensure you get the best experience on our website.
The cookies do not store any personalised information. Learn More